Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine ...Middle East

PR Newswire - News
Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine
LONG BEACH, Calif., Aug. 2, 2024 /PRNewswire/ -- Anivive Lifesciences Inc, a One Health technology company today announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded Anivive a new contract...

Hence then, the article about anivive receives niaid contract worth up to 33m to progress valley fever vaccine was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine )

Apple Storegoogle play

Last updated :

Also on site :